US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

33.73

-0.8400-2.43%

Post-market: 33.730.00000.00%17:06 EDT

Volume:288.05K

Turnover:9.93M

Market Cap:949.37M

PE:-19.06

High:35.49

Open:35.35

Low:33.65

Close:34.57

Loading ...

Overview Company News Filings

Modus Therapeutics Completes Enrollment in Phase 2a Study of Sevuparin

IRLAB Therapeutics Concludes Trading in Rights Issue Subscription

Prescient Therapeutics Announces Cessation of Securities

Chordia Therapeutics Reports Continued Losses in Latest Financial Results

JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Stock Catapults 25% Though Its Price And Business Still Lag The Industry

Simply Wall St.

Alterity Therapeutics Addresses ASX Price Query Amid Market Anticipation

Crispr Therapeutics AG Stock Soars Amid Strategic Moves

Major Stock Sell-Offs at Entrada Therapeutics: What You Need to Know!

MiNK Therapeutics downgraded to Market Perform from Outperform at William Blair

Rein Therapeutics Amends By-Laws for Quorum Requirement

Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI

ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI

Prelude Therapeutics’ PRT7732 Study: A Potential Game-Changer for SMARCA4 Mutations

Mersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study

Plus Therapeutics Advances Pediatric Brain Tumor Treatment with New Clinical Study

Promising Clinical Results and Positive Outlook for MiNK Therapeutics’ agenT-797 Drive Buy Rating

Rakovina Therapeutics Applauds Variational AI’s Award for AI-Driven Drug Discovery

Mink Therapeutics Inc trading halted, volatility trading pause

Aligos Therapeutics announces inducement grants under Nasdaq listing rule

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LENZ/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":33.73,"timestamp":1752868800000,"preClose":34.57,"halted":0,"volume":288046,"hourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"delay":0,"floatShares":12538526,"shares":28146154,"eps":-1.769251,"marketStatus":"Market Closed","change":-0.84,"latestTime":"07-18 16:00:00 EDT","open":35.35,"high":35.485,"low":33.645,"amount":9926090.220002001,"amplitude":0.053225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":34.57,"preHourTrading":{"tag":"盘前","latestPrice":35.3,"preClose":34.57,"latestTime":"09:29 EDT","volume":499,"amount":17604.058825,"timestamp":1752845399999},"postHourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"volumeRatio":0.803536,"impliedVol":1.0249,"impliedVolPercentile":0.8986},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12538526,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.803536,"shares":28146154,"dividePrice":0,"high":35.485,"amplitude":0.053225,"preClose":34.57,"low":33.645,"week52Low":16.535,"pbRate":"4.94","week52High":38.93,"institutionHeld":0,"latestPrice":33.73,"eps":-1.769251,"divideRate":0,"volume":288046,"delay":0,"ttmEps":-1.769251,"open":35.35,"prevYearClose":28.87,"prevWeekClose":34.69,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":34.69,"twentyDayClose":30.03,"sixtyDayClose":25.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551972582","title":"Modus Therapeutics Completes Enrollment in Phase 2a Study of Sevuparin","url":"https://stock-news.laohu8.com/highlight/detail?id=2551972582","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551972582?lang=en_us&edition=fundamental","pubTime":"2025-07-14 14:32","pubTimestamp":1752474777,"startTime":"0","endTime":"0","summary":"Karolinska Development AB ( ($SE:KDEV) ) has provided an update. Karolinska Development’s portfolio company, Modus Therapeutics, has completed pati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/modus-therapeutics-completes-enrollment-in-phase-2a-study-of-sevuparin?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/modus-therapeutics-completes-enrollment-in-phase-2a-study-of-sevuparin?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2551971230","title":"IRLAB Therapeutics Concludes Trading in Rights Issue Subscription","url":"https://stock-news.laohu8.com/highlight/detail?id=2551971230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551971230?lang=en_us&edition=fundamental","pubTime":"2025-07-14 13:33","pubTimestamp":1752471190,"startTime":"0","endTime":"0","summary":"An update from IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) is now available. IRLAB Therapeutics AB announced the last day for trading subscript...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-concludes-trading-in-rights-issue-subscription?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-concludes-trading-in-rights-issue-subscription?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2551601975","title":"Prescient Therapeutics Announces Cessation of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2551601975","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551601975?lang=en_us&edition=fundamental","pubTime":"2025-07-14 11:47","pubTimestamp":1752464841,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics Limited ( ($AU:PTX) ) has issued an announcement. Prescient Therapeutics Limited announced the cessation of 1,000,000 securi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-announces-cessation-of-securities-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-announces-cessation-of-securities-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2551978175","title":"Chordia Therapeutics Reports Continued Losses in Latest Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2551978175","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551978175?lang=en_us&edition=fundamental","pubTime":"2025-07-14 10:52","pubTimestamp":1752461532,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Chordia Therapeutics Inc. ( ($JP:190A) ). Chordia Therapeutics Inc. reported its non-consolidated financial res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chordia-therapeutics-reports-continued-losses-in-latest-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chordia-therapeutics-reports-continued-losses-in-latest-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2551277329","title":"JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Stock Catapults 25% Though Its Price And Business Still Lag The Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2551277329","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551277329?lang=en_us&edition=fundamental","pubTime":"2025-07-14 08:35","pubTimestamp":1752453326,"startTime":"0","endTime":"0","summary":"Despite an already strong run, JW (Cayman) Therapeutics Co. Ltd ( HKG:2126 ) shares have been powering on, with a gain...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2126/jw-cayman-therapeutics-shares/news/jw-cayman-therapeutics-co-ltd-hkg2126-stock-catapults-25-tho","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02126","BK4539","BK1574","BK1161","BK4139","LENZ","BK4007","BK1583"],"gpt_icon":0},{"id":"2551929483","title":"Alterity Therapeutics Addresses ASX Price Query Amid Market Anticipation","url":"https://stock-news.laohu8.com/highlight/detail?id=2551929483","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551929483?lang=en_us&edition=fundamental","pubTime":"2025-07-14 08:18","pubTimestamp":1752452308,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has provided an update. Alterity Therapeutics Limited has responded to a price query from the ASX regarding a r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-addresses-asx-price-query-amid-market-anticipation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-addresses-asx-price-query-amid-market-anticipation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2550187959","title":"Crispr Therapeutics AG Stock Soars Amid Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2550187959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550187959?lang=en_us&edition=fundamental","pubTime":"2025-07-12 22:04","pubTimestamp":1752329091,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 10.96%. Read on to learn why. Crispr Therapeutics AG has seen a significant boost in its stock pric...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-strategic-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-strategic-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","BK4139","BK4588","BK4007","BK4210","BK4539","BK4556","LENZ","LU1861558580.USD","LU1861559042.SGD","AG","CRSP","BK4585"],"gpt_icon":0},{"id":"2550988993","title":"Major Stock Sell-Offs at Entrada Therapeutics: What You Need to Know!","url":"https://stock-news.laohu8.com/highlight/detail?id=2550988993","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550988993?lang=en_us&edition=fundamental","pubTime":"2025-07-12 10:01","pubTimestamp":1752285673,"startTime":"0","endTime":"0","summary":"New insider activity at Entrada Therapeutics Inc ( ($TRDA) ) has taken place on July 11, 2025. Director Kush Parmar has sold 27,000 shares of Entra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stock-sell-offs-at-entrada-therapeutics-what-you-need-to-know-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stock-sell-offs-at-entrada-therapeutics-what-you-need-to-know-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","TRDA","BK4539"],"gpt_icon":0},{"id":"2550503964","title":"MiNK Therapeutics downgraded to Market Perform from Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2550503964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550503964?lang=en_us&edition=fundamental","pubTime":"2025-07-12 05:20","pubTimestamp":1752268815,"startTime":"0","endTime":"0","summary":"William Blair downgraded MiNK Therapeutics (INKT) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2550615089","title":"Rein Therapeutics Amends By-Laws for Quorum Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2550615089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550615089?lang=en_us&edition=fundamental","pubTime":"2025-07-12 04:35","pubTimestamp":1752266129,"startTime":"0","endTime":"0","summary":"An announcement from Rein Therapeutics ( ($RNTX) ) is now available. On July 10, 2025, Rein Therapeutics‘ Board of Directors amended the company’s ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rein-therapeutics-amends-by-laws-for-quorum-requirement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rein-therapeutics-amends-by-laws-for-quorum-requirement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2550965318","title":"Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2550965318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550965318?lang=en_us&edition=fundamental","pubTime":"2025-07-12 02:15","pubTimestamp":1752257734,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Gavin Clark-Gartner lowered the firm’s price target on Dyne Therapeutics (DYN) to $41 from $46 and keeps an Outperform rating ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dyne-therapeutics-price-target-lowered-to-41-from-46-at-evercore-isi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dyne-therapeutics-price-target-lowered-to-41-from-46-at-evercore-isi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DYN","LENZ"],"gpt_icon":0},{"id":"2550653439","title":"ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550653439?lang=en_us&edition=fundamental","pubTime":"2025-07-12 02:15","pubTimestamp":1752257722,"startTime":"0","endTime":"0","summary":"Evercore ISI raised the firm’s price target on ProQR Therapeutics (PRQR) to $5 from $4 and keeps an Outperform rating on the shares. The firm adjus...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/proqr-therapeutics-price-target-raised-to-5-from-4-at-evercore-isi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/proqr-therapeutics-price-target-raised-to-5-from-4-at-evercore-isi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2550950742","title":"Prelude Therapeutics’ PRT7732 Study: A Potential Game-Changer for SMARCA4 Mutations","url":"https://stock-news.laohu8.com/highlight/detail?id=2550950742","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550950742?lang=en_us&edition=fundamental","pubTime":"2025-07-12 00:15","pubTimestamp":1752250506,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics, Inc. (($PRLD)) announced an update on their ongoing clinical study. Prelude Therapeutics, Inc. is conducting a Phase 1 study ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-prt7732-study-a-potential-game-changer-for-smarca4-mutations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-prt7732-study-a-potential-game-changer-for-smarca4-mutations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRLD","LENZ","BK4139","BK4539","BK4505"],"gpt_icon":0},{"id":"2550950717","title":"Mersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2550950717","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550950717?lang=en_us&edition=fundamental","pubTime":"2025-07-12 00:13","pubTimestamp":1752250395,"startTime":"0","endTime":"0","summary":"Mersana Therapeutics (($MRSN)) announced an update on their ongoing clinical study. Study Overview: Mersana Therapeutics is conducting a Phase 1 cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mersana-therapeutics-advances-her2-targeted-cancer-therapy-with-xmt-2056-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mersana-therapeutics-advances-her2-targeted-cancer-therapy-with-xmt-2056-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2550950094","title":"Plus Therapeutics Advances Pediatric Brain Tumor Treatment with New Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2550950094","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550950094?lang=en_us&edition=fundamental","pubTime":"2025-07-12 00:13","pubTimestamp":1752250383,"startTime":"0","endTime":"0","summary":"Plus Therapeutics (($PSTV)) announced an update on their ongoing clinical study. Plus Therapeutics is conducting a clinical study titled A Two-Part...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/plus-therapeutics-advances-pediatric-brain-tumor-treatment-with-new-clinical-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/plus-therapeutics-advances-pediatric-brain-tumor-treatment-with-new-clinical-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2550876957","title":"Promising Clinical Results and Positive Outlook for MiNK Therapeutics’ agenT-797 Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550876957","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550876957?lang=en_us&edition=fundamental","pubTime":"2025-07-11 23:05","pubTimestamp":1752246314,"startTime":"0","endTime":"0","summary":"Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on MiNK Therapeutics. The associated price target remains the same with $3...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-results-and-positive-outlook-for-mink-therapeutics-agent-797-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-results-and-positive-outlook-for-mink-therapeutics-agent-797-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2550895283","title":"Rakovina Therapeutics Applauds Variational AI’s Award for AI-Driven Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2550895283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550895283?lang=en_us&edition=fundamental","pubTime":"2025-07-11 22:33","pubTimestamp":1752244398,"startTime":"0","endTime":"0","summary":"An announcement from Rakovina Therapeutics Inc ( ($TSE:RKV) ) is now available. Rakovina Therapeutics Inc. congratulates its partner, Variational A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-applauds-variational-ais-award-for-ai-driven-drug-discovery?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-applauds-variational-ais-award-for-ai-driven-drug-discovery?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2550959277","title":"Mink Therapeutics Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2550959277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550959277?lang=en_us&edition=fundamental","pubTime":"2025-07-11 21:35","pubTimestamp":1752240907,"startTime":"0","endTime":"0","summary":"09:34 EDT Mink Therapeutics (INKT) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, mark...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","INKT","LENZ"],"gpt_icon":0},{"id":"2550554729","title":"Aligos Therapeutics announces inducement grants under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2550554729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550554729?lang=en_us&edition=fundamental","pubTime":"2025-07-11 20:35","pubTimestamp":1752237321,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to pur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LU2095319765.USD","NVIW.SI","USAW.SI","QID","USJW.SI","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","BK4112","LENZ","IE00B64PRP62.GBP","BK4007","QLD","BK4139","BK4539","NQmain","BK4585","TSYW.SI","SQQQ",".IXIC","IE00BGHQF748.EUR","LU2210150020.SGD","MNQmain","TQQQ","ALGS","NDAQ","IE00B3QW5Z07.USD","PSQ"],"gpt_icon":0},{"id":"2550678955","title":"Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550678955","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550678955?lang=en_us&edition=fundamental","pubTime":"2025-07-11 20:30","pubTimestamp":1752237000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., July  11, 2025  (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/11/3113985/0/en/Aligos-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","BK4539","IE00BGHQF748.EUR","LENZ",".IXIC","IE00B64PRP62.GBP","BK4505","BK4007","BK4585","ALGS","BK4588","BK4112","BK4139","LU2210149790.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-17","current":-20.747029,"percent":0,"low":-20.747029,"twenty":-15.811799,"median":-10.788339,"eighty":-7.479638,"high":-5.069183,"avg":-11.383781,"sd":4.077823,"marketCap":990463159},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-17","current":-20.747029,"twenty":-15.811799,"median":-10.788339,"eighty":-7.479638,"marketCap":990463159}],"updateTime":1752902791928}}}